TI
NVAX icon

Trexquant Investment’s Novavax NVAX Stock Holding History

Trexquant Investment’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,085
Closed -$1.21M – 1775
2024
Q4 		$1.21M Sell
150,085
-516,572
-77% -$4.98M 0.01% 1039
2024
Q3 		$8.42M Buy
+666,657
New +$8.61M 0.11% 288
2022
Q3 		– Sell
-18,805
Closed -$967K – 1705
2022
Q2 		$967K Buy
+18,805
New +$974K 0.04% 532
2016
Q2 		– Sell
-10,250
Closed -$1.06M – 1021
2016
Q1 		$1.06M Buy
+10,250
New +$1.1M 0.12% 278
2015
Q4 		– Sell
-835
Closed -$117K – 1201
2015
Q3 		$117K Buy
835
+45
+6% +$10.1K 0.01% 991
2015
Q2 		$176K Sell
790
-8,864
-92% -$1.56M 0.02% 927
2015
Q1 		$1.6M Buy
+9,654
New +$1.57M 0.16% 185

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trexquant Investment's NVAX Position: Q1 2025 in Review

Trexquant Investment sold out of Novavax (NVAX) in Q1 2025, closing a stake of 150,085 shares — an estimated $1.21M sold.

Trexquant Investment first reported a position in NVAX in Q1 2015 and held it in 7 quarters. The position peaked at $8.42M in Q3 2024. 245 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Trexquant Investment reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Trexquant Investment sold 150,085 Novavax shares in Q1 2025, an estimated $1.21M.
  • Trexquant Investment first reported a position in Novavax in Q1 2015 and held it in 7 quarters.
  • Trexquant Investment's Novavax position peaked at $8.42M in Q3 2024.
  • 245 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Trexquant Investment's 13F filing for Q1 2025, filed 14 May 2025.